Buy Ovid Therapeutics Stock | OVID Stock Price & Latest News | Public
OVID

Ovid Therapeutics

$0.00 (0.00%)Today

    About OVID

    Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY. The full company name is Ovid Therapeutics, Inc....

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.14
    -0.27
    -0.41
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.36

    Actual EPS
    Q3 2020

    Stats

    Market Cap$423,69M
    Volume38,63k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.40
    1 Year Low$1.80
    Open$6.58
    High$6.90
    Low$6.58

    Buy any stock with any amount of money.

    Download the App
    Download the app